Grant: Discovery Grants Program - Individual
University of Calgary
$32,000.00
Droplet based surface microfluidic bio-microsystems
EF 2014-15
Résumé
The development of miniaturized total analysis microsystems (µTAS) or often referred to as Lab-on-a-chip (LOC) is of increasing interest among the research community. This technology potentially offers new prospects for routine chemical analysis, drug testing, bioassay, and health care delivery, diagnostic devices including non-invasive and early detection of cancers.In this regard our research effort will specifically focus on the development and application of a novel droplet based surface microfluidic technology to: (1) Facilitate manipulation of biological cells, both healthy and cancerous, based on their measured dielectrophoretic signatures, (2) Provide multiplex sample handling for chip based biochemical assays and (3) assemble heterogeneous emulsion droplets and lipid bilayer vesicles for biosensing, drug encapsulation and delivery applications.The droplet based dielectrophoresis (DEP) fluidic microsystem when integrated with other microsystem sub-systems provides a low-cost platform technology, capable of rapid and sensitive diagnosis of early stage cancerous fingerprints of biological cells, nucleic acids (DNA, RNA) and/or proteins, and potentially ""in-field"": detection of pathogens and environmental toxins. The successful commercialization and deployment of such proposed microfluidic microsystems has the potentials to revolutionize the availability and delivery of cost effective, population wide, health care..
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
4790-2011
Name nom
Kaler, Karan
Department département
Electrical and Computer Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2011
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
4
Nb partie
5
Application title
Droplet based surface microfluidic bio-microsystems
Keyword
NSERC
Application summary
The development of miniaturized total analysis microsystems (µTAS) or often referred to as Lab-on-a-chip (LOC) is of increasing interest among the research community. This technology potentially offers new prospects for routine chemical analysis, drug testing, bioassay, and health care delivery, diagnostic devices including non-invasive and early detection of cancers.In this regard our research effort will specifically focus on the development and application of a novel droplet based surface microfluidic technology to: (1) Facilitate manipulation of biological cells, both healthy and cancerous, based on their measured dielectrophoretic signatures, (2) Provide multiplex sample handling for chip based biochemical assays and (3) assemble heterogeneous emulsion droplets and lipid bilayer vesicles for biosensing, drug encapsulation and delivery applications.The droplet based dielectrophoresis (DEP) fluidic microsystem when integrated with other microsystem sub-systems provides a low-cost platform technology, capable of rapid and sensitive diagnosis of early stage cancerous fingerprints of biological cells, nucleic acids (DNA, RNA) and/or proteins, and potentially ""in-field"": detection of pathogens and environmental toxins. The successful commercialization and deployment of such proposed microfluidic microsystems has the potentials to revolutionize the availability and delivery of cost effective, population wide, health care..